Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions

The development of novel therapies against melanoma would benefit from individualized tumor models to ensure the rapid and accurate identification of biomarkers of therapy response. Previous studies have suggested that patient-derived xenografts (PDXes) could be useful. However, the utility of PDXes...

Descripción completa

Detalles Bibliográficos
Autores principales: Einarsdottir, Berglind O., Bagge, Roger Olofsson, Bhadury, Joydeep, Jespersen, Henrik, Mattsson, Jan, Nilsson, Lisa M., Truvé, Katarina, López, Marcela Dávila, Naredi, Peter, Nilsson, Ola, Stierner, Ulrika, Ny, Lars, Nilsson, Jonas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259423/
https://www.ncbi.nlm.nih.gov/pubmed/25228592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259423/
https://www.ncbi.nlm.nih.gov/pubmed/25228592

Ejemplares similares